Blog

Cancer survivors can now have access to more resources for cancer care or post-cancer needs at Providence Saint John’s new survivorship program. Read more.

Clinical trials are the lifeblood of medical advances. Without these studies, new treatments would simply not emerge. Find out about the clinical trials program at Saint John’s Cancer Institute which has significantly expanded its clinical trials program and expects to have more than 60 trials underway by the end of 2017.

At the Pacific Brain Tumor Center, we provide comprehensive care for patients with all types of brain tumors, including benign and malignant brain tumors, tumors of the skull base as well as metastatic brain tumors that arise from cancers elsewhere in the body. See more.

We are pleased to announce a new clinical trial using the Optune device. Ongoing trials in stroke, quality & outcomes research & brain cancer are actively recruiting. Read more.

We are pleased to present our new clinical trials this month. Find out about our studies in stroke and quality & outcomes research as well as brain cancer.

The 2nd annual microdissection lab/ lecture conference brings clinical & research teams together to learn about anatomical strategies for brain cancer surgery. Find out more.

Many young people’s lives are affected by brain cancer. Read about this mother's determination to do something about it and raise money for cancer research.

For many decades, cancers have been described—and even treated—according to the type of organ from which the cancer arises, such as lung, breast or brain. But increasingly doctors are looking at genetic information to determine how to best treat their patients and increase the chances...

A review of new research and treatments for brain cancer in 2016  TJ was diagnosed with a stage III Astrocytoma brain tumor at the age of 14. Even after four brain surgeries, several courses of radiation over 5 years, many kinds of chemotherapy, experimental treatments,...

We have added a new clinical trial to our roster of brain tumor trials at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Orbus Therapeutics (NCT02796261): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine...